David K. Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
David K. Kim has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Paul Hunter
University of Wisconsin, School of Medicine and Public Health, Madison, Wisconsin
3 shared publications- Achamyeleh Gebremariam
Susan B. Meister Child Health Evaluation and Research Center, University of Michigan, Ann Arbor, MI 48109, USA
1 shared publication - Amy Parker Fiebelkorn
Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop H24-4, Atlanta, GA 30326, United States
1 shared publication - Angela M. Rose
Susan B. Meister Child Health Evaluation and Research Center, University of Michigan, Ann Arbor, United States
1 shared publication - Ann J. Cloud
Abt Associates Inc, 10 Fawcett St, Suite 5, Cambridge, Massachusetts, United States
1 shared publication - Aparna Ramakrishnan
Devi Partners, San Carlos, CA 94070, USA
1 shared publication
Latest Publications
- Open Access
- 29 July 2019
- Published by Springer Nature in Journal of Patient-Reported Outcomes
- Vol. 3 (1) , 1-12
Use of a choice survey to identify adult, adolescent and parent preferences for vaccination in the United States
Adult and adolescent vaccination rates are far below coverage targets in the United States. Our objective was to identify the most influential factors related to vaccine uptake among adults, adolescents, and parents of adolescents (parents) in the United States. We used a fractional factorial design to create a binary choice survey to evaluate preferences for vaccination. The national survey was fielded to a sample of adults, adolescents ages 13–17 years, and parents, using a national probability-based online research panel in November 2015. Respondents were presented with 5 profiles of a hypothetical vaccine and asked in a series of questions whether they would accept each vaccine. We analyzed the binary choice data using logistic regression in STATA v13 (College Station, TX) to calculate the odds that a participant would choose to accept the vaccine. We received completed responses from 334 (51%) of 652 adults, 316 (21%) of 1516 adolescents, and 339 (33%) of 1030 parents. Respondents were generally representative of the U.S. population. Vaccine effectiveness was the most influential factor in the choice to vaccinate for all groups. Other most influential factors were primary care provider (PCP) recommendation and the out-of-pocket cost of the vaccine. Other factors such as risk of illness, risk of vaccine side effects, vaccination location, and time for vaccination were not important in the decision to get vaccinated. Adults, adolescents, and parents are most sensitive to vaccine effectiveness, PCP recommendation, and out-of-pocket cost for vaccination in their decision to get vaccinated. Strong PCP recommendations that focus on vaccine effectiveness and health care policies that minimize out-of-pocket costs for vaccinations may increase vaccine uptake by adults and adolescents.
- 29 July 2019
- Published by Springer Nature in Journal of Patient-Reported Outcomes
- Vol. 3 (1) , 1-12
Open AccessUse of a choice survey to identify adult, adolescent and parent preferences for vaccination in the United States
Adult and adolescent vaccination rates are far below coverage targets in the United States. Our objective was to identify the most influential factors related to vaccine uptake among adults, adolescents, and parents of adolescents (parents) in the United States. We used a fractional factorial design to create a binary choice survey to evaluate preferences for vaccination. The national survey was fielded to a sample of adults, adolescents ages 13–17 years, and parents, using a national probability-based online research panel in November 2015. Respondents were presented with 5 profiles of a hypothetical vaccine and asked in a series of questions whether they would accept each vaccine. We analyzed the binary choice data using logistic regression in STATA v13 (College Station, TX) to calculate the odds that a participant would choose to accept the vaccine. We received completed responses from 334 (51%) of 652 adults, 316 (21%) of 1516 adolescents, and 339 (33%) of 1030 parents. Respondents were generally representative of the U.S. population. Vaccine effectiveness was the most influential factor in the choice to vaccinate for all groups. Other most influential factors were primary care provider (PCP) recommendation and the out-of-pocket cost of the vaccine. Other factors such as risk of illness, risk of vaccine side effects, vaccination location, and time for vaccination were not important in the decision to get vaccinated. Adults, adolescents, and parents are most sensitive to vaccine effectiveness, PCP recommendation, and out-of-pocket cost for vaccination in their decision to get vaccinated. Strong PCP recommendations that focus on vaccine effectiveness and health care policies that minimize out-of-pocket costs for vaccinations may increase vaccine uptake by adults and adolescents.
- Open Access
- 25 March 2019
- Published by Elsevier in American Journal of Transplantation
- Vol. 19 (4) , 1232-1235
Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older — United States, 2019
- 25 March 2019
- Published by Elsevier in American Journal of Transplantation
- Vol. 19 (4) , 1232-1235
Open AccessAdvisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older — United States, 2019
- Open Access
- 8 February 2019
- Published by Centers for Disease Control MMWR Office in MMWR. Morbidity and Mortality Weekly Report
- Vol. 68 (5) , 115-118
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2019
In October 2018, the Advisory Committee on Immunization Practices voted to recommend approval of the Recommended Adult Immunization Schedule for Adults Aged 19 years or Older, United States, 2019.
- 8 February 2019
- Published by Centers for Disease Control MMWR Office in MMWR. Morbidity and Mortality Weekly Report
- Vol. 68 (5) , 115-118
Open AccessAdvisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2019
In October 2018, the Advisory Committee on Immunization Practices voted to recommend approval of the Recommended Adult Immunization Schedule for Adults Aged 19 years or Older, United States, 2019.
- Open Access
- 5 February 2019
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 170 (3) , 182-192
Recommended Adult Immunization Schedule, United States, 2019*
- 5 February 2019
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 170 (3) , 182-192
Open AccessRecommended Adult Immunization Schedule, United States, 2019*